PMID- 30818913
OWN - NLM
STAT- MEDLINE
DCOM- 20190528
LR  - 20190528
IS  - 1007-3418 (Print)
IS  - 1007-3418 (Linking)
VI  - 27
IP  - 2
DP  - 2019 Feb 20
TI  - [Organizing an assembly to eliminate hepatitis B virus through a project zero 
      mother-to-child transmission of hepatitis B virus].
PG  - 102-105
LID - 10.3760/cma.j.issn.1007-3418.2019.02.006 [doi]
AB  - The China Foundation of Hepatitis Prevention and Control (CFHPC) initiated a 
      project named, "getting to zero mother-to-child transmission of Hepatitis B," in 
      July 2015, which aims to further reduce the incidence of mother-to-child 
      transmission through standardized follow-up management of pregnant women and 
      their infants with chronic hepatitis B virus infection by means of mobile medical 
      application. Over the past three years, the project has established a nationwide 
      collaborative network for interruption of mother-to-child transmission of 
      hepatitis B virus, with 123 hospitals as project members. In addition, it has 
      formulated a technical guidance document (Clinical Management Algorithm for 
      Interrupting Mother-to-Child Transmission of HBV), which is designed and 
      developed as a mobile medical application (SHIELD APP), and was released in an 
      international conference on the theme to eliminate viral hepatitis. Following the 
      measures mentioned above, the public's awareness rate of hepatitis B have been 
      raised, and a good social atmosphere has been formed, which has played a positive 
      role in promoting the prevention and control of viral hepatitis in China.
FAU - Liu, Z H
AU  - Liu ZH
AD  - Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, 
      Guangzhou 510515, China.
FAU - Li, Z D
AU  - Li ZD
AD  - Chinese Foundation of Hepatitis Prevention and Control, Beijing 100050, China.
FAU - Yang, X Z
AU  - Yang XZ
AD  - Chinese Foundation of Hepatitis Prevention and Control, Beijing 100050, China.
FAU - Hou, J L
AU  - Hou JL
AD  - Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, 
      Guangzhou 510515, China.
LA  - chi
GR  - 2017ZX10201201/"Thirteenth Five-Year Plan" Major National Science and Technology 
      Major Projects/
GR  - 81673243/National Natural Science Foundation of China/
PT  - Journal Article
PL  - China
TA  - Zhonghua Gan Zang Bing Za Zhi
JT  - Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of 
      hepatology
JID - 9710009
RN  - 0 (Antiviral Agents)
RN  - 0 (Hepatitis B Surface Antigens)
RN  - 0 (Hepatitis B Vaccines)
RN  - 0 (Hepatitis B e Antigens)
SB  - IM
MH  - Antiviral Agents/*therapeutic use
MH  - Child
MH  - China/epidemiology
MH  - Female
MH  - Hepatitis B/epidemiology/*prevention & control
MH  - Hepatitis B Surface Antigens
MH  - Hepatitis B Vaccines/administration & dosage/immunology
MH  - Hepatitis B e Antigens
MH  - *Hepatitis B virus
MH  - Humans
MH  - Infant
MH  - Infectious Disease Transmission, Vertical/*prevention & control
MH  - Pregnancy
MH  - Pregnancy Complications, Infectious/*drug therapy/epidemiology/*virology
OTO - NOTNLM
OT  - Hepatitis B virus
OT  - Mother-to-child transmission
OT  - Shield project aiming zero mother-to-child transmission of hepatitis B virus
EDAT- 2019/03/02 06:00
MHDA- 2019/05/29 06:00
CRDT- 2019/03/02 06:00
PHST- 2019/03/02 06:00 [entrez]
PHST- 2019/03/02 06:00 [pubmed]
PHST- 2019/05/29 06:00 [medline]
AID - 10.3760/cma.j.issn.1007-3418.2019.02.006 [doi]
PST - ppublish
SO  - Zhonghua Gan Zang Bing Za Zhi. 2019 Feb 20;27(2):102-105. doi: 
      10.3760/cma.j.issn.1007-3418.2019.02.006.